BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37494767)

  • 1. Butyrate reverses ferroptosis resistance in colorectal cancer by inducing c-Fos-dependent xCT suppression.
    He Y; Ling Y; Zhang Z; Mertens RT; Cao Q; Xu X; Guo K; Shi Q; Zhang X; Huo L; Wang K; Guo H; Shen W; Shen M; Feng W; Xiao P
    Redox Biol; 2023 Sep; 65():102822. PubMed ID: 37494767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
    Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
    Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocyte-Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer.
    Zhang Q; Deng T; Zhang H; Zuo D; Zhu Q; Bai M; Liu R; Ning T; Zhang L; Yu Z; Zhang H; Ba Y
    Adv Sci (Weinh); 2022 Oct; 9(28):e2203357. PubMed ID: 35978266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance-mediated oxaliplatin chemoresistance in colorectal cancer.
    Xu Y; Hao J; Chen Q; Qin Y; Qin H; Ren S; Sun C; Zhu Y; Shao B; Zhang J; Wang H
    Mol Carcinog; 2024 Feb; 63(2):224-237. PubMed ID: 37861356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactobacillus plantarum-derived metabolites sensitize the tumor-suppressive effects of butyrate by regulating the functional expression of SMCT1 in 5-FU-resistant colorectal cancer cells.
    Kim HJ; An J; Ha EM
    J Microbiol; 2022 Jan; 60(1):100-117. PubMed ID: 34964946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer.
    Chang CC; Kao WY; Liu CY; Su HH; Kan YA; Lin PY; Ku WC; Chang KW; Yang RN; Huang CJ
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35417036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer.
    Wang G; Wang JJ; Zhi-Min Z; Xu XN; Shi F; Fu XL
    Sci Prog; 2023; 106(1):368504221147173. PubMed ID: 36718538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Butyrate-Resistant Colorectal Cancer Cell Lines and the Cytotoxicity of Anticancer Drugs against These Cells.
    Nittayaboon K; Leetanaporn K; Sangkhathat S; Roytrakul S; Navakanitworakul R
    Biomed Res Int; 2022; 2022():6565300. PubMed ID: 35909471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
    Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
    Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
    [No Abstract]   [Full Text] [Related]  

  • 10. FAM98A promotes resistance to 5-fluorouracil in colorectal cancer by suppressing ferroptosis.
    He Z; Yang J; Sui C; Zhang P; Wang T; Mou T; Sun K; Wang Y; Xu Z; Li G; Deng H; Shi J; Zhuang B
    Arch Biochem Biophys; 2022 Jun; 722():109216. PubMed ID: 35421356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jianpi Jiedu decoction reverses 5-fluorouracil resistance in colorectal cancer by suppressing the xCT/GSH/GPX4 axis to induce ferroptosis.
    Ou QL; Cheng L; Chang YL; Liu JH; Zhang SF
    Heliyon; 2024 Mar; 10(5):e27082. PubMed ID: 38455561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox Regulation of Stem-like Cells Though the CD44v-xCT Axis in Colorectal Cancer: Mechanisms and Therapeutic Implications.
    Ju HQ; Lu YX; Chen DL; Tian T; Mo HY; Wei XL; Liao JW; Wang F; Zeng ZL; Pelicano H; Aguilar M; Jia WH; Xu RH
    Theranostics; 2016; 6(8):1160-75. PubMed ID: 27279909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colorectal Cancer.
    Zeng K; Li W; Wang Y; Zhang Z; Zhang L; Zhang W; Xing Y; Zhou C
    Adv Sci (Weinh); 2023 Sep; 10(25):e2301088. PubMed ID: 37428466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7H3 increases ferroptosis resistance by inhibiting cholesterol metabolism in colorectal cancer.
    Jin H; Zhu M; Zhang D; Liu X; Guo Y; Xia L; Chen Y; Chen Y; Xu R; Liu C; Xi Q; Xia S; Shi T; Zhang G
    Cancer Sci; 2023 Nov; 114(11):4225-4236. PubMed ID: 37661645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
    Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
    Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
    [No Abstract]   [Full Text] [Related]  

  • 16. Blockade of GCH1/BH4 Axis Activates Ferritinophagy to Mitigate the Resistance of Colorectal Cancer to Erastin-Induced Ferroptosis.
    Hu Q; Wei W; Wu D; Huang F; Li M; Li W; Yin J; Peng Y; Lu Y; Zhao Q; Liu L
    Front Cell Dev Biol; 2022; 10():810327. PubMed ID: 35223839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy.
    Gomes S; Rodrigues AC; Pazienza V; Preto A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL17 coordinates ferroptosis and tumorigenesis by regulating mitochondrial translation in colorectal cancer.
    Li H; Yu K; Hu H; Zhang X; Zeng S; Li J; Dong X; Deng X; Zhang J; Zhang Y
    Redox Biol; 2024 May; 71():103087. PubMed ID: 38377789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145.
    Gao R; Fang C; Xu J; Tan H; Li P; Ma L
    Arch Biochem Biophys; 2019 Mar; 663():183-191. PubMed ID: 30639170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 facilitates tumor progression by inducing ferroptosis resistance in head and neck squamous cell carcinoma.
    Li M; Jin S; Zhang Z; Ma H; Yang X
    Cancer Lett; 2022 Feb; 527():28-40. PubMed ID: 34902522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.